Maybe, Mark, I could mention just a couple of key investments that were made in the public domain. One was in the National Research Council Royalmount facility, where construction of a whole new biologics manufacturing centre is under way.
The second is in VIDO, which is a public sector investment attached to the University of Saskatchewan, where there's been very significant investment, as well, both in manufacturing and vaccine candidates.